Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIP Chemotherapy for High Risk Pediatric Germ Cell Tumor
NCT05455918Phase 2Recruiting
- Sponsor
- Yonsei University
- Start
- Jul 2020
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, ifosfamide, cisplatin in germ cell tumor (GCT), sponsored by Yonsei University. Started Jul 2020; status: recruiting.
02
Drugs
paclitaxelifosfamidecisplatin
03
Conditions
germ cell tumor (GCT)
Beyond the preview
Go deeper on NCT05455918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05455918.